
BRIDGEWATER, N.J. and SALT LAKE CITY, June 02, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, ...

51-week clinical study confirms that Sandoz proposed biosimilar adalimumab matches reference medicine Humira®* safety ...
Click to continue to site. Closing